Literature DB >> 11714608

Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter.

X H Gu1, R Zong, N S Kula, R J Baldessarini, J L Neumeyer.   

Abstract

A series of novel fluoroalkyl-containing tropane derivatives was synthesized, and their binding affinities for the dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) were determined via competitive binding assays. Among these derivatives, the fluoropropyl ester of beta-CIT (19), the fluoroethyl ester of beta-CIT (20), the N-fluoropropyl derivative of beta-CBT (12), and the fluoropropyl ester of beta-CMT (18) displayed higher affinity and greater selectivity for the DAT versus SERT and NET than FP-CIT, which indicates that they are attractive candidates for the development of (18)F-labeled PET imaging agents for the DAT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714608     DOI: 10.1016/s0960-894x(01)00626-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

2.  Radiosynthesis and validation of ¹⁸F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain.

Authors:  Paul Cumming; Simone Maschauer; Patrick J Riss; Nuska Tschammer; Stefanie K Fehler; Markus R Heinrich; Torsten Kuwert; Olaf Prante
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-09       Impact factor: 6.200

3.  Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.

Authors:  Aurelija Jucaite; Ikuo Odano; Hans Olsson; Stefan Pauli; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-03       Impact factor: 9.236

4.  Monoamine transporter availability in Parkinson's disease patients with or without depression.

Authors:  Swen Hesse; Philipp M Meyer; Karl Strecker; Henryk Barthel; Florian Wegner; Christian Oehlwein; Ioannis Ugo Isaias; Johannes Schwarz; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-27       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.